Voluntis and AliveCor Partner to Advance Management of Atrial Fibrillation for Patients with Cancer
Voluntis and AliveCor Partner to Advance Management of Atrial Fibrillation for Patients with CancerCambridge, Massachusetts and Mountain View, California, January 6, 2022 - Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced that it has entered into a partnership agreement with Aliv...
Source: pharmiweb.com